UPDATE ON VACCINE IN INDIA AND WORLD
Covaxin approved for emergency use for children between 2-18 years.
Covaxin approved for emergency use for children between 2-18 years.
The WHO has authorized the deployment of the world's first malaria vaccine in sub-Saharan Africa and other high-risk regions. The ...
The WHO has authorized the deployment of the world's first malaria vaccine in sub-Saharan Africa and other high-risk regions. The ...
People, who have been vaccinated with both the doses of Covaxin, India’s indigenous vaccine developed by Bharat Biotech, would not ...
THD NewsDesk, New Delhi: Supreme Court ask Government to explain the different prices of covid vaccines ahead of the Centre’s ...
THD NewsDesk, New Delhi: Amidst the major crisis of vaccines in the country when the country is seeing fatalities in a ...
THD News Desk, New Delhi: As a response to bridging the gap between demand and supply of vaccines in India, ...
THD NewsDesk, New Delhi: On Wednesday, Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture PLC, Bengaluru ...
The country observed 251 new Covid-19 losses during the same time, taking the combined toll to 1,47,343. There are 2,81,667 ...
Serum Institute of India (SII), the world’s largest vaccine producer, claimed that last week that, it soon expected emergency use ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily